This is a single case report, so it cannot show that any treatment works for others. It describes one 74-year-old woman with hepatitis B related cirrhosis. She was diagnosed with primary clear cell carcinoma of the liver, a rare type of liver cancer. Doctors treated her with laparoscopic partial hepatectomy, a minimally invasive surgery to remove part of the liver, followed by TACE, a procedure that delivers chemotherapy directly into the liver's blood supply.
From 2022 to 2025, she remained free of recurrence or metastasis. The report does not describe any side effects or safety problems. It also does not report whether the TACE was necessary, since a single case cannot separate the effect of surgery from the effect of TACE.
The report stresses that surgery is the main treatment for this kind of cancer, and that careful tissue testing is needed to confirm the diagnosis. Because this is one patient, the results are early and uncertain. Readers should not assume this approach will work the same way for anyone else. People facing a liver cancer diagnosis should talk with their care team about their own options.
Common questions
What is primary clear cell carcinoma of the liver?
It is a rare type of liver cancer. This case report describes a 74-year-old woman with hepatitis B related cirrhosis who was diagnosed with it. Doctors confirmed the diagnosis using tissue testing. Because it is uncommon, careful lab testing is important to tell it apart from other liver cancers.
What treatments did the patient receive?
She had laparoscopic partial hepatectomy, which is surgery to remove part of the liver through small openings. After surgery, she had TACE, a procedure that delivers chemotherapy directly into the liver's blood supply. The report does not say whether the TACE was required or how much it helped.
Did the cancer come back?
The report says she was free of recurrence or metastasis from 2022 to 2025. That is a good outcome for this one patient. However, a single case cannot show that the treatment will prevent cancer from returning in other people.
Were there any side effects?
The report does not describe any side effects, serious events, or treatment stops. That does not mean the treatments are risk-free. Surgery and TACE both carry risks, and anyone considering them should ask their doctor about what to expect.
Can I rely on this for my own treatment decisions?
No. This is one case report, which is the weakest kind of medical evidence. It cannot prove that surgery plus TACE works better than other options. Surgery is described as the main treatment for this cancer, but your care team is the best source of advice for your situation.
